Allogene Therapeutics is a clinical-stage biotechnology company focused on pioneering the development of investigational allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease
Allogene Therapeutics is a clinical-stage biotechnology company focused on pioneering the development of investigational allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease.